User Experience with Pegcetacoplan On-Body Injector in Patients with C3 Glomerulopathy or Primary Immune-Complex Membranoproliferative Glomerulonephritis
Journal of the American Society of Nephrology · 2026-10 · 37 (10S)
DOI: 10.1681/asn.2026260tp3f8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Abdallah Sassine Geara und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Geara, A. S., Price-Schluns, M., Huang, M., Perler, J., Hadker, N., Torres, A. C., Hill, L., Gonzalez, N., & Gordon, K. (2026). User Experience with Pegcetacoplan On-Body Injector in Patients with C3 Glomerulopathy or Primary Immune-Complex Membranoproliferative Glomerulonephritis. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.2026260tp3f8
Vancouver
Geara AS, Price-Schluns M, Huang M, Perler J, Hadker N, Torres AC, et al. User Experience with Pegcetacoplan On-Body Injector in Patients with C3 Glomerulopathy or Primary Immune-Complex Membranoproliferative Glomerulonephritis. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.2026260tp3f8
BibTeX
@article{Geara2026,
author = {Geara, Abdallah Sassine and Price-Schluns, Megan and Huang, Mingyi and Perler, Jed and Hadker, Nandini and Torres, Amanda Cassidy and Hill, Laura and Gonzalez, Nicholas and Gordon, Katie},
title = {User Experience with Pegcetacoplan On-Body Injector in Patients with C3 Glomerulopathy or Primary Immune-Complex Membranoproliferative Glomerulonephritis},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {10S},
doi = {10.1681/asn.2026260tp3f8}
}
EUVIMED